This fall was packed with four must-see webinars! If you missed out, they’re all available on demand for you to watch at your convenience.
...
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by laura, 05-09-2011, 04:42 AM
|
35 responses
105,542 views
0 likes
|
Last Post
by Guest
12-05-2013, 02:37 AM
|
||
Started by sci_guy, 01-23-2008, 11:19 PM
|
236 responses
673,934 views
1 like
|
Last Post
by ECO
12-25-2009, 06:45 PM
|
||
Started by brachysclereid, 09-29-2011, 07:42 AM
|
1 response
2,690 views
0 likes
|
Last Post
by IBseq
10-16-2012, 02:43 AM
|
||
Started by shuang, 10-15-2012, 12:28 PM
|
3 responses
2,427 views
0 likes
|
Last Post
by sklages
10-16-2012, 12:27 AM
|
||
Started by swNGS, 07-09-2012, 09:39 AM
|
6 responses
3,016 views
0 likes
|
Last Post
by Chipper
10-15-2012, 11:57 PM
|
||
Started by mathew, 10-15-2012, 09:36 AM
|
2 responses
2,066 views
0 likes
|
Last Post
by nanto
10-15-2012, 11:42 PM
|
||
Started by fabrice, 08-05-2011, 05:30 AM
|
8 responses
7,612 views
0 likes
|
Last Post
by arkal
10-15-2012, 09:10 PM
|
||
Started by stemcell, 10-13-2012, 10:17 AM
|
2 responses
4,088 views
0 likes
|
Last Post
by stemcell
10-15-2012, 12:39 PM
|
||
Started by JQL, 10-15-2012, 12:29 PM
|
0 responses
1,306 views
0 likes
|
Last Post
by JQL
10-15-2012, 12:29 PM
|
||
Started by cpleis, 10-08-2012, 01:44 PM
|
8 responses
4,532 views
0 likes
|
Last Post
by cpleis
10-15-2012, 09:31 AM
|
||
Started by cantabile, 10-14-2012, 06:20 PM
|
2 responses
1,375 views
0 likes
|
Last Post
by cantabile
10-15-2012, 08:56 AM
|
||
Started by AdrianJ217, 10-15-2012, 12:40 AM
|
7 responses
2,142 views
0 likes
|
Last Post
by AdrianJ217
10-15-2012, 04:58 AM
|
No topics found.
-
Page of 0
-
Filter
Webinars
Collapse
Recent Articles
Collapse
-
by seqadmin
Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...-
Channel: Articles
12-16-2024, 07:57 AM -
-
by seqadmin
Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.
Long-Read Sequencing
Long-read sequencing has seen remarkable advancements,...-
Channel: Articles
12-02-2024, 01:49 PM -
-
by seqadmin
The field of immunogenetics explores how genetic variations influence immune responses and susceptibility to disease. In a recent SEQanswers webinar, Oscar Rodriguez, Ph.D., Postdoctoral Researcher at the University of Louisville, and Ruben Martínez Barricarte, Ph.D., Assistant Professor of Medicine at Vanderbilt University, shared recent advancements in immunogenetics. This article discusses their research on genetic variation in antibody loci, antibody production processes,...-
Channel: Articles
11-06-2024, 07:24 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 12-17-2024, 10:28 AM
|
0 responses
23 views
0 likes
|
Last Post
by seqadmin
12-17-2024, 10:28 AM
|
||
Started by seqadmin, 12-13-2024, 08:24 AM
|
0 responses
42 views
0 likes
|
Last Post
by seqadmin
12-13-2024, 08:24 AM
|
||
Started by seqadmin, 12-12-2024, 07:41 AM
|
0 responses
28 views
0 likes
|
Last Post
by seqadmin
12-12-2024, 07:41 AM
|